Showing 2 posts of 32 posts found.
Pfizer’s heart pill Inspra has gained a new licence in the UK to reduce the risk of death in patients …
Pfizer is to end a clinical trial of Inspra early because of signs that it significantly cuts the risk of …
Care Quality Commission appoints Emily Miles as Chief Executive
National survey aims to improve glaucoma care across the UK
Phase 3 trials support expanded use of Dysport for migraine prevention
Roche secures CE Mark for automated latent tuberculosis blood test
ReproNovo Phase 2 fertility study doses first participant